首页 › 股票 › VRDN

VRDN — VIRIDIAN THERAPEUTICS INC

申报持仓市值$3.97B
持有基金数(最新)448
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q3 2026)220
机构持仓市值$2.31B · 220.62M 股
新建/增持/减仓/清仓56 / 81 / 39 / 81 · 更新于 2026-11-16
前五大/前十大集中度41.1% / 57.1%
机构整体持仓变动 增持 +5.7% (+10.04M 股)
机构持仓市值变动 上升 +24.0%

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

截至Q3 2026,共 220 家机构在其最新 13F 申报中持有 VRDN(VIRIDIAN THERAPEUTICS INC),合计申报市值 $2.31B,对应 220.62M 股。按股数计算较上季度增持 5.7%(+10.04M 股),申报市值环比上升 24.0%。持仓集中度较高:前五大持有人占申报市值的 41.1%,前十大的集中度为 57.1%。

与上一季度相比,56 家新建仓位、81 家加仓、39 家减仓、81 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。

VIRIDIAN THERAPEUTICS INC(VRDN)的主要机构持有人包括 Fidelity Management & Research (FMR)、Paradigm Biocapital Advisors LP、Vanguard Group,按 13F 申报市值在本页 448 家持有人中排名居前。

VRDN 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 220 220.62M $2.31B +5.8%
Q2 2026 244 301.56M $2.44B +68.1%
Q1 2026 232 118.41M $2.26B +4.6%
Q4 2025 232 114.44M $3.45B +9.3%
Q3 2025 170 99.36M $2.09B -0.5%
Q2 2025 171 99.84M $1.36B +4.1%
Q1 2025 177 95.81M $1.27B +1.6%
Q4 2024 178 92.99M $1.76B +6.2%

表内 8 个季度中,机构持股合计增加 137%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(+68.1%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 17.51M $360.51M 0.02% 增持
Paradigm Biocapital Advisors LP 历史持仓 12.41M $227.08M 4.51% 增持
VANGUARD CAPITAL MANAGEMENT LLC 7.20M $131.41M 0.00% 增持
Kynam Capital Management, LP 历史持仓 6.15M $126.59M 7.01% 减持
STATE STREET CORP 5.10M $103.47M 0.00% 增持
RTW INVESTMENTS, LP 历史持仓 4.98M $102.03M 1.03% 新进
WELLINGTON MANAGEMENT GROUP LLP 3.69M $76.00M 0.01% 增持
Geode Capital Management 3.29M $64.38M 0.00% 增持
Deep Track Capital, LP 历史持仓 3.83M $64.34M 1.07% 增持
Atlas Venture Life Science Advisors, LLC 历史持仓 4.50M $61.83M 9.80% 新进
Context Capital Management, LLC 历史持仓 49.00M $56.47M 1.87% 增持
Avoro Capital Advisors LLC 历史持仓 2.50M $51.48M 0.53% 持有
VANGUARD PORTFOLIO MANAGEMENT LLC 2.42M $49.77M 0.00% 减持
DIMENSIONAL FUND ADVISORS LP 1.75M $36.11M 0.01% 增持
Parkman Healthcare Partners LLC 历史持仓 1.67M $34.48M 3.11% 增持
Trails Edge Capital Partners, LP 历史持仓 2.50M $34.27M 4.92% 新进
Candriam S.C.A. 1.53M $31.55M 0.14% 减持
First Turn Management, LLC 历史持仓 1.53M $31.40M 4.17% 减持
TCG Crossover Management, LLC 历史持仓 2.20M $30.15M 0.85% 新进
RICE HALL JAMES & ASSOCIATES, LLC 历史持仓 1.24M $25.45M 1.35% 增持
Bank of America Corp 1.23M $25.39M 0.00% 增持
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.28M $24.32M 0.00% 增持
Blue Owl Capital Holdings LP 历史持仓 1.58M $22.42M 4.21% 增持
DeepCurrents Investment Group LLC 历史持仓 19.46M $22.26M 0.74% 增持
Northern Trust Corp 1.04M $20.72M 0.00% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 16.60M $305.03M 0.01% 增持
Bellevue Group AG 历史持仓 6.73M $123.67M 2.60% 持有
Paradigm Biocapital Advisors LP 历史持仓 6.72M $123.52M 2.31% 增持
Kynam Capital Management, LP 历史持仓 6.45M $118.56M 6.55% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 5.75M $105.60M 0.01% 增持
Fairmount Funds Management LLC 历史持仓 5.09M $93.52M 6.18% 增持
VANGUARD CAPITAL MANAGEMENT LLC 4.58M $84.08M 0.00% 增持
Deep Track Capital, LP 历史持仓 3.59M $66.00M 0.98% 增持
Venrock Adviser, LLC 历史持仓 3.26M $59.85M 1.81% 减持
Wellington Management Group 3.13M $57.47M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 3.13M $57.47M 0.01% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 2.75M $50.57M 0.00% 增持
GEODE CAPITAL MANAGEMENT, LLC 2.50M $45.97M 0.00% 新进
Geode Capital Management 2.50M $45.97M 0.00% 增持
Avoro Capital Advisors LLC 历史持仓 2.50M $45.92M 0.41% 增持
Context Capital Management, LLC 历史持仓 40.75M $43.82M 1.27% 新进
BAKER BROS. ADVISORS LP 历史持仓 2.38M $43.78M 0.23% 增持
Caligan Partners LP 历史持仓 2.19M $40.30M 2.36% 新进
Novo Holdings A/S 历史持仓 2.13M $39.22M 2.28% 增持
TANG CAPITAL MANAGEMENT LLC 历史持仓 1.79M $32.93M 1.50% 持有
Fisher Asset Management, LLC 1.75M $32.16M 0.01% 减持
Candriam S.C.A. 1.71M $31.34M 0.14% 增持
Goldman Sachs Group 1.69M $31.07M 0.01% 增持
First Turn Management, LLC 历史持仓 1.67M $30.68M 3.28% 增持
DIMENSIONAL FUND ADVISORS LP 1.61M $29.61M 0.01% 增持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 15.38M $300.82M 0.02% 增持
BlackRock Inc 7.83M $153.18M 0.01% 增持
Bellevue Group AG 历史持仓 6.73M $131.56M 3.13% 增持
STATE STREET CORP 4.67M $91.40M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 4.17M $81.51M 0.00% 新进
Fairmount Funds Management LLC 历史持仓 3.91M $76.57M 5.53% 持有
Venrock Adviser, LLC 历史持仓 3.88M $75.95M 2.83% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 3.21M $62.71M 0.01% 减持
Paradigm Biocapital Advisors LP 历史持仓 3.15M $61.59M 1.26% 增持
Wellington Management Group 3.08M $60.22M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 3.08M $60.22M 0.01% 增持
Kynam Capital Management, LP 历史持仓 2.34M $45.80M 2.95% 增持
Geode Capital Management 2.33M $45.65M 0.00% 增持
Balyasny Asset Management 2.32M $45.30M 0.15% 增持
ALLIANCEBERNSTEIN L.P. 1.39M $43.32M 0.01% 减持
Novo Holdings A/S 历史持仓 2.00M $39.12M 3.17% 减持
BAKER BROS. ADVISORS LP 历史持仓 1.97M $38.57M 0.23% 持有
TANG CAPITAL MANAGEMENT LLC 历史持仓 1.79M $35.06M 1.78% 持有
Fisher Asset Management, LLC 1.77M $34.59M 0.01% 减持
VANGUARD PORTFOLIO MANAGEMENT LLC 1.64M $32.11M 0.00% 新进
Goldman Sachs Group 1.59M $31.14M 0.01% 增持
Avoro Capital Advisors LLC 历史持仓 1.50M $29.34M 0.36% 持有
Deep Track Capital, LP 历史持仓 1.39M $27.27M 0.45% 减持
D. E. Shaw & Co 1.26M $24.70M 0.02% 增持
D. E. Shaw & Co., Inc. 1.26M $24.70M 0.05% 增持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 14.38M $447.64M 0.02% 增持
BlackRock Inc 6.43M $200.16M 0.01% 增持
Vanguard Group 5.61M $174.65M 0.00% 增持
Bellevue Group AG 历史持仓 4.36M $135.64M 2.57% 新进
Fairmount Funds Management LLC 历史持仓 3.91M $121.82M 9.27% 增持
Venrock Adviser, LLC 历史持仓 3.88M $120.83M 5.97% 持有
STATE STREET CORP 3.47M $107.88M 0.00% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 3.44M $107.04M 0.01% 增持
PERCEPTIVE ADVISORS LLC 3.04M $94.69M 1.79% 增持
Deep Track Capital, LP 历史持仓 2.52M $78.57M 1.40% 减持
Novo Holdings A/S 历史持仓 2.38M $74.07M 5.75% 持有
Geode Capital Management 1.99M $62.01M 0.00% 增持
BAKER BROS. ADVISORS LP 历史持仓 1.97M $61.36M 0.38% 增持
Wellington Management Group 1.97M $61.35M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 1.97M $61.35M 0.01% 增持
TANG CAPITAL MANAGEMENT LLC 历史持仓 1.79M $55.79M 2.76% 减持
Eversept Partners, LP 1.78M $55.46M 2.79% 减持
Fisher Asset Management, LLC 1.78M $55.40M 0.02% 增持
Morgan Stanley 1.74M $54.09M 0.00% 增持
Avoro Capital Advisors LLC 历史持仓 1.50M $46.68M 0.51% 新进
LOOMIS SAYLES & CO L P 1.48M $46.09M 0.06% 减持
Kynam Capital Management, LP 历史持仓 1.47M $45.76M 3.06% 减持
Paradigm Biocapital Advisors LP 历史持仓 1.44M $44.91M 1.15% 减持
ALLIANCEBERNSTEIN L.P. 1.41M $44.01M 0.01% 减持
Marshall Wace 1.38M $42.81M 0.06% 增持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 12.25M $264.34M 0.01% 持有
BlackRock Inc 5.43M $117.15M 0.00% 减持
Deep Track Capital, LP 历史持仓 5.38M $116.11M 3.24% 持有
Kynam Capital Management, LP 历史持仓 4.43M $95.55M 7.11% 持有
Vanguard Group 4.33M $93.48M 0.00% 减持
Venrock Adviser, LLC 历史持仓 3.88M $83.79M 4.72% 持有
Fairmount Funds Management LLC 历史持仓 3.46M $74.66M 6.72% 持有
Commodore Capital LP 3.20M $69.06M 3.37% 减持
TANG CAPITAL MANAGEMENT LLC 历史持仓 2.84M $61.35M 2.36% 持有
Paradigm Biocapital Advisors LP 历史持仓 2.61M $56.31M 1.88% 减持
STATE STREET CORP 2.55M $55.12M 0.00% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 2.42M $52.18M 0.01% 减持
Novo Holdings A/S 历史持仓 2.38M $51.36M 3.31% 持有
MAVERICK CAPITAL LTD 2.21M $47.75M 0.65% 减持
Maverick Capital 2.21M $47.75M 0.64% 减持
Eversept Partners, LP 1.92M $41.53M 3.09% 增持
ALLIANCEBERNSTEIN L.P. 1.86M $40.13M 0.01% 减持
Geode Capital Management 1.77M $38.12M 0.00% 增持
BAKER BROS. ADVISORS LP 历史持仓 1.74M $37.64M 0.28% 持有
LOOMIS SAYLES & CO L P 1.55M $33.46M 0.04% 增持
PERCEPTIVE ADVISORS LLC 1.46M $31.56M 0.95% 增持
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.22M $26.33M 0.04% 增持
Fisher Asset Management, LLC 1.20M $25.92M 0.01% 增持
Parkman Healthcare Partners LLC 历史持仓 1.15M $24.91M 2.60% 减持
WELLINGTON MANAGEMENT GROUP LLP 1.12M $24.22M 0.01% 增持

Q2 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 12.24M $171.10M 0.01% 持有
BlackRock Inc 5.52M $77.18M 0.00% 减持
Deep Track Capital, LP 历史持仓 5.38M $75.22M 2.42% 持有
Commodore Capital LP 4.88M $68.15M 4.81% 增持
Vanguard Group 4.51M $63.03M 0.00% 减持
Kynam Capital Management, LP 历史持仓 4.43M $61.90M 6.67% 减持
Venrock Adviser, LLC 历史持仓 3.88M $54.28M 4.07% 持有
Fairmount Funds Management LLC 历史持仓 3.46M $48.37M 6.27% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 2.90M $40.48M 0.01% 增持
TANG CAPITAL MANAGEMENT LLC 历史持仓 2.84M $39.74M 2.01% 增持
Paradigm Biocapital Advisors LP 历史持仓 2.74M $38.33M 1.64% 增持
STATE STREET CORP 2.55M $35.70M 0.00% 减持
Novo Holdings A/S 历史持仓 2.38M $33.27M 2.35% 增持
MAVERICK CAPITAL LTD 2.26M $31.55M 0.48% 增持
Maverick Capital 2.26M $31.55M 0.47% 增持
ALLIANCEBERNSTEIN L.P. 1.94M $27.18M 0.01% 减持
Eversept Partners, LP 1.90M $26.60M 2.45% 增持
BAKER BROS. ADVISORS LP 历史持仓 1.74M $24.39M 0.24% 新进
Geode Capital Management 1.74M $24.34M 0.00% 增持
LOOMIS SAYLES & CO L P 1.34M $18.71M 0.02% 减持
Parkman Healthcare Partners LLC 历史持仓 1.30M $18.16M 2.09% 增持
Pictet Asset Management Holding SA 1.27M $17.70M 0.02% 增持
Marshall Wace 1.21M $16.89M 0.03% 增持
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.11M $15.50M 0.03% 减持
Vivo Capital, LLC 982.58K $13.74M 1.41% 持有

查看全部 448 家持有基金 →

新建仓(Q3 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Fidelity Management & Research (FMR) 17.51M 16.60M 15.38M 14.38M 12.25M 12.24M 12.22M 11.88M 11.18M 9.57M 9.42M 7.63M 262.19K 261.76K 144.15K 1.20K 443 69 — —
Paradigm Biocapital Advisors LP 12.41M 6.72M 3.15M 1.44M 2.61M 2.74M 2.10M 1.82M 2.90M 2.90M 5.03M 4.79M 3.68M — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 7.20M 4.58M 4.17M — — — — — — — — — — — — — — — — —
Kynam Capital Management, LP 6.15M 6.45M 2.34M 1.47M 4.43M 4.43M 4.70M 3.33M 2.51M 1.75M 133.88K 607.91K 699.68K — — — — — — —
STATE STREET CORP 5.10M — 4.67M 3.47M 2.55M 2.55M 2.87M 3.52M 2.38M 2.77M 4.49M 2.71M 2.94M — — — — — — —
RTW INVESTMENTS, LP 4.98M — — — — — — — — 605.82K 605.82K 605.82K — — — — — — — —
WELLINGTON MANAGEMENT GROUP LLP 3.69M 3.13M 3.08M 1.97M 1.12M 270.54K 249.17K 224.48K 235.99K 284.04K 240.83K 192.10K 215.65K — — — — — — —
Geode Capital Management 3.29M 2.50M 2.33M 1.99M 1.77M 1.74M 1.72M 1.66M 1.49M 1.41M 1.16M 994.47K 859.10K 860.86K 776.11K 710.99K 599.77K 449.66K 199.24K 201.68K
Deep Track Capital, LP 3.83M 3.59M 1.39M 2.52M 5.38M 5.38M 5.38M 4.52M 3.75M 3.92M 3.46M 3.63M 2.96M — — — — — — —
Atlas Venture Life Science Advisors, LLC 4.50M — — — — — — — — — — — — — — — — — — —
Context Capital Management, LLC 49.00M 40.75M — — — — — — — — — — — — — — — — — —
Avoro Capital Advisors LLC 2.50M 2.50M 1.50M 1.50M — — — — — — — — — — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 2.42M 2.75M 1.64M — — — — — — — — — — — — — — — — —
DIMENSIONAL FUND ADVISORS LP 1.75M 1.61M 529.76K 555.59K 638.78K 485.70K — 55.92K 327.08K 107.58K 10.07K 10.07K 10.07K — — — — — — —
Parkman Healthcare Partners LLC 1.67M 1.38M 557.94K 788.08K 1.15M 1.30M 1.06M 1.09M 425.00K — — — — — — — — — — —
Trails Edge Capital Partners, LP 2.50M — — — — — — — — — — — — — — — — — — —
Candriam S.C.A. 1.53M 1.71M 711.74K 785.10K 860.23K 862.27K 880.43K 731.22K 749.80K 749.80K 280.00K — — — — — — — — —
First Turn Management, LLC 1.53M 1.67M 911.34K 690.53K — — — — — — — — — — — — — — — —
TCG Crossover Management, LLC 2.20M — — — — — — — — — — — — — — — — — — —
RICE HALL JAMES & ASSOCIATES, LLC 1.24M 1.18M 898.61K 884.53K 851.66K 515.62K 362.89K 53.38K — — — — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold VRDN?

As of 2026-Q3, 220 institutional funds reported holding VRDN (VIRIDIAN THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.31B.

How many shares of VRDN do institutions own?

13F filers reported 220.62M shares of VRDN, worth $2.31B in aggregate at the end of 2026-Q3.

Is institutional ownership of VRDN rising or falling?

Share counts moved +5.7% versus the prior quarter — accumulation.

Who are the top institutional holders of VRDN?

The largest 13F holders are Fidelity Management & Research (FMR), Paradigm Biocapital Advisors LP, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Kynam Capital Management, LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of VIRIDIAN THERAPEUTICS INC?

The major shareholders of VIRIDIAN THERAPEUTICS INC (VRDN) by reported 13F value are Fidelity Management & Research (FMR), Paradigm Biocapital Advisors LP, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Kynam Capital Management, LP, among 448 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 VRDN」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/VRDN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →